Natco Pharma approves 1 percent stake acquisition in Canadian arm
New Delhi: Drug major Natco Pharma on Friday said its board has approved acquiring about 1 per cent stake in its Canadian subsidiary .
The company, however, did not disclose the value of the deal.
"The board of directors of the company at their meeting approved to acquire 0.96 per cent stake in Natco Pharma (Canada) Inc., after this acquisition Natco Pharma (Canada) Inc., (will) become a wholly owned subsidiary company of Natco Pharma Ltd," Hyderabad-based Natco Pharma said in a regulatory filing.
Read also: Natco marketing partner Breckenridge Pharma gets USFDA nod for cancer drug Everolimus
The company did not share any more details.
Read also: Natco Pharma ventures into Pheromone based technology for Integrated Pest Management
Next Story